Data Biologics, Llc announced it raised $95,000 in an amended filing from an offering of $2 Million

Company

Location

About

DataBiologics is solving a major problem with the lack of evidence and transparency for safety and efficacy in the emerging field of Regenerative Medicine. Today, these therapies are primarily cash-pay and use the patient’s own tissue healing response or cells as the source of treatment, such as those found in blood, fat, and bone marrow.